Summary
Non-synonymous coding variants of IFIH1 have been associated with various autoimmune phenotypes, most particularly type 1 diabetes (T1D).
1
Cellular and biochemical assays indicate that these mutations confer gain of function such that mutant IFIH1 binds RNA more avidly, leading to increased baseline and ligand-induced interferon signaling.
2
This suggests that coding variants in IFIH1 can cause diseases by aberrant sensing of nucleic acids, resulting in immune upregulation.
2
According to